COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab

被引：0
|
作者：
Sufana Shikdar
Azra Borogovac
Elabdallah Mohamad
Mohamad Khawandanah
机构：
[1] University of Oklahoma Health Sciences Center,Department of Hematology/Oncology, Stephenson Cancer Center
[2] University of Oklahoma Medical Center (OUMC),Department of Internal Medicine
[3] University of Oklahoma Health Sciences Center,Hematology/Oncology fellow, Department of Medicine, Division of Hematology
来源：
Thrombosis Journal | / 19卷
关键词：
COVID19; Paroxysmal nocturnal hemoglobinuria; Complement inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab
    Shikdar, Sufana
    Borogovac, Azra
    Mohamad, Elabdallah
    Khawandanah, Mohamad
    THROMBOSIS JOURNAL, 2021, 19 (01)
  • [2] COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria A case report
    Sokol, Juraj
    Nehaj, Frantisek
    Mokan, Michal
    Lisa, Lenka
    Stasko, Jan
    MEDICINE, 2021, 100 (20)
  • [3] Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Lee, Jong Wook
    Kulasekararaj, Austin G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (03) : 227 - 237
  • [4] Ravulizumab in the treatment of paroxysmal nocturnal hemoglobinuria
    Rho, Hayeong
    Wells, Richard A.
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (08): : 257 - 264
  • [5] Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Burns, Ethan
    Anand, Kartik
    Acosta, Gonzalo
    Irani, Malcolm
    Chung, Betty
    Maiti, Abhishek
    Ibrahim, Ibrahim
    Rice, Lawrence
    CASE REPORTS IN HEMATOLOGY, 2019,
  • [6] COST-EFFECTIVENESS OF RAVULIZUMAB COMPARED WITH ECULIZUMAB FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN THE NETHERLANDS
    Quist, S.
    Postma, A. J.
    Myren, K. J.
    de Jong, L.
    Postma, M. J.
    VALUE IN HEALTH, 2022, 25 (12) : S99 - S99
  • [7] No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab
    Alashkar, Ferras
    Rottinghaus, Scott
    Vance, Colin
    Herich-Terhuerne, Doerte
    Duehrsen, Ulrich
    Assert, Roland
    Roeth, Alexander
    PLOS ONE, 2020, 15 (03):
  • [8] PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PNH
    Hamed, Hanan
    LEUKEMIA RESEARCH, 2017, 61 : S6 - S6
  • [9] Paroxysmal nocturnal hemoglobinuria PNH
    Hamed, Hanan
    LEUKEMIA RESEARCH, 2018, 73 : S2 - S2
  • [10] Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment
    Roeth, A.
    Duehrsen, U.
    Schrezenmeier, H.
    Schubert, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (09) : 404 - 409
12345